ACRO Biomedical Revenue

ACRO Biomedical had revenue of 13.32M TWD in the half year ending June 30, 2025, a decrease of -15.74%. This brings the company's revenue in the last twelve months to 36.50M, down -35.18% year-over-year. In the year 2024, ACRO Biomedical had annual revenue of 44.23M, down -13.38%.

Revenue (ttm)

36.50M

Revenue Growth

-35.18%

P/S Ratio

119.08

Revenue / Employee

n/a

Employees

n/a

Market Cap

4.35B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	44.23M	-6.83M	-13.38%
Dec 31, 2023	51.06M	23.43M	84.79%
Dec 31, 2022	27.63M	5.81M	26.59%
Dec 31, 2021	21.83M	3.80M	21.04%
Dec 31, 2020	18.03M	10.71M	146.35%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
OBI Pharma	58.58M
Medigen Biotechnology	1.58B
Formosa Pharmaceuticals	9.50M
Senhwa Biosciences	1.07M
Sagittarius Life Science	346.08M
Pharmosa Biopharm	67.27M
BioGend Therapeutics	222.34M
Energenesis Biomedical CO.,LTD.	7.67M

Revenue Rankings